Core Viewpoint - The company emphasizes its commitment to research and innovation, accelerating the secondary development of major products, and systematically advancing ongoing projects while enhancing the output of research results [1] Group 1: Research and Development - The company has received national approval for the project of the raw material and capsules of S-Right Methylphenidate [1] - The company has obtained clinical trial approval for Semaglutide injection [1] - The company is deepening the integration of industry, academia, and medical research, and has been approved for the establishment of the Chongqing Traditional Chinese Medicine New Drug Creation and Intelligent Manufacturing Technology Innovation Center [1]